MEDTECH LEADERS AGENDA
Choose your topic ... Biotech Healthtech Medtech
*** 17:30 - 20:00 Tuesday 10th October - Stay with us for the networking reception ***
Day 1 - Tuesday 10th October
08:50 Welcome Address
Josh Dance, SVP, LSX
09:00 Live Opening Of The Nasdaq Nordic Markets & Nasdaq Welcome
Carsten Borring, Head of Listings & Capital Markets, NASDAQ Copenhagen
09:10 Back Bay Welcome Address
Jonathan Gertler, CEO, BackBay Life Science Advisors
09:20 Unleashing The Global Potential Of The Nordic Life Science Markets Through Strategic Internationalization
The Nordic region has long been recognized as a global leader in innovation, sustainability, and quality of life, and has also emerged as a hotbed for life science innovation and entrepreneurship with an increasing number of startups. The Nordic region shares a highly interconnected business environment that facilitates cross-border collaboration and knowledge exchange, creating a unique ecosystem that fosters innovation and entrepreneurship, attracting investors and partners from around the world. Despite these advantages, however, the Nordic life science markets face a number of challenges in their efforts to grow and internationalize. This keynote discussion will explore the current state of the Nordic life science markets, including their strengths and weaknesses, and discuss strategies for growing and globalizing the industry in the years ahead.
10:10 How Can Nordic Life Sciences Continue To Be A Global Leader?
AstraZeneca has a bold aspiration to launch 15 new medicines over the coming years and become carbon-neutral. As a Swedish-British company with more than 84.000 employees globally, the company plays a leading role in the Nordics as well as global life sciences.
With increased globalization and competition, what is needed if the Nordics should continue to be a leader within life sciences?
Christof Bischoff, Country Director, Denmark, AstraZeneca
10:30 Morning Break
11:00 Northern Lights - Illuminating International Investment Opportunities In Nordic Medtech
With one of the densest and most innovative life clusters in the world, the Nordic life science offering is attracting the attention of investors worldwide. As innovation and competition ramps up, medtech companies who understand what these investors are looking for will pull to the front of the pack. A panel of international medtech investors discuss the Nordic market, tapping and how medtech companies best position themselves for investment.
11:50 Paths To Partnership And Navigating Acquisition For Future Growth
Medtech may be facing headwinds due to staffing shortages and cutbacks in medical device procurement, leading to a 62% drop in M&A value last year. But, the industry is bouncing back with a spike in M&A activity in Q4 2022, with a focus on developing digital capabilities and collaborating to unlock personalized treatments. In 2024, Medtech companies are expected to work collaboratively to promote interoperability of healthcare data, with Big MedTech companies seeking external innovation to improve efficiency. A panel of industry leaders will discuss the exciting partnering and deal-making landscape across the Nordic region, including identifying early-stage technology start-ups, BD strategies, areas of innovation, and acquisition opportunities.
12:40 Lunch Break
13:45 Uniting For Better Healthcare - How Medtech Companies And Nordic Hospitals Can Bridge The Gap
Nordic hospitals face severe pressure with increasing waiting times for operations, nurse shortages, and the risk of compromised patient health. The healthcare sector urgently needs innovation to alleviate the burden on clinicians. A panel of experts discusses how medtech companies can step up and meet this critical need.
14:40 Scaling Up In The Nordics - Funding Strategies For Medtech Entrepreneurs
The Nordic region's emphasis on entrepreneurship and innovation has driven economic growth for decades, but concerns have been raised about the long-term viability of the Nordic model for startups looking to scale. Startups need to focus on sustainable growth, well-balanced partnerships, and networking to succeed. Despite challenges faced by the investment industry in 2022, PE deal count in the Nordics increased and VC deal activity remained strong. With such a lucrative start-up environment, a panel of international and local investors discuss how medtech companies can stand-out from the crowd.
15:30 Afternoon Break
16:00 The Value Of Nordic Medtech Collaboration
Collaboration among medtech companies is essential for consolidating Nordic economies and societies and staying competitive globally. Although Sweden and Denmark lead the pack in market size, collaboration should involve rapidly growing life science hotspots in Norway and Finland. Nordic countries should develop a framework for efficient and secure data sharing, promote collaborative innovation and knowledge sharing, and encourage cross-border investment and partnerships. By fostering a culture of collaboration and coordination and leveraging their collective strengths, the life science cluster can be further strengthened and cement its position as a leading cluster and hub. A panel of industry leaders discuss why and how medtech leaders should take advantage of inter-regional collaboration.
16:50 From Data To Diagnosis - Digitisation And The Future Of Nordic Medtech
The Nordic medtech industry is undergoing a significant transformation through digitisation. Companies are embracing innovative technologies like AI and natural language interpretation to enhance their products and services, leading to faster and more accurate diagnoses, personalised treatment plans and improved patient outcomes. However, regulatory and legal considerations, as well as IP protection and innovation, remain important challenges. As the industry continues to evolve, it is crucial for medtech companies to stay at the forefront of innovation while balancing patient safety and compliance with applicable laws.
17:30 Drinks Reception
Day 2 - Wednesday 11th October
11:00 Welcome Introductions
Tim Damgaard-Christensen, Managing Partner, EU, MedTech Bridge
11:05 Bridging The Gap from Market To Revenue Based Valuation - How Long Is Your Runway?
Micael Törnblom, CEO, CYTO365
Q&A & General Discussion
11:25 The Next Step: Exploring Opportunities Beyond The Nordic Region
Jon Hoem, CEO, Pacertool
Q&A & General Discussion
11:45 General Discussion
(suggested topics to include but not limited to)
12:00 End of Forum
Company Showcases
Day 1 – Tuesday 10th October
15:30 | ![]()
|
15:45 | ![]()
|
16:00 | ![]()
|
16:15 | ![]()
|
16:30 | ![]()
|
16:45 | ![]()
|
17:00 | ![]()
|
17:15 | ![]()
|
Expert Investor Panel
|
Day 2 – Wednesday 11th October
10:45 | ![]()
|
11:00 | ![]() |
11:15 | ![]()
|
11:30 | ![]()
|
11:45 | ![]()
|
12:00 | ![]()
|
12:15 |
|
12:30 |
|
Day 2 - Wednesday 11th October - 11:00
11:00 Welcome Introductions
Tim Damgaard-Christensen, Managing Partner, EU, MedTech Bridge
11:05 Bridging The Gap from Market To Revenue Based Valuation - How Long Is Your Runway?
Micael Törnblom, CEO, CYTO365
Q&A & General Discussion
11:25 The Next Step: Exploring Opportunities Beyond The Nordic Region
Jon H. Hoem, CEO, Pacertool
Q&A & General Discussion
11:45 General Discussion
(suggested topics to include but not limited to)
12:00 End of Forum
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd